Overview of patency as an end point of thrombolytic therapy
- 5 December 1991
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 68 (16) , 11-16
- https://doi.org/10.1016/0002-9149(91)90300-a
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.Circulation, 1987
- Anisoylated plasminogen streptokinase activator complex in acute myocardial infarction: A placebo-controlled arteriographic coronary recanalization studyJournal of the American College of Cardiology, 1987
- Early thrombolysis in acute myocardial infarction: Limitation of infarct size and improved survivalJournal of the American College of Cardiology, 1986
- DOUBLE-BLIND RANDOMISED TRIAL OF INTRAVENOUS TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS PLACEBO IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1985
- The Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1985
- Acute myocardial infarction treated with intracoronary streptokinase: A report of the society for cardiac angiographyThe American Journal of Cardiology, 1985
- A randomized trial of intravenous and intracoronary streptokinase in patients with acute myocardial infarction.Circulation, 1984
- Randomized comparison of intravenous versus intracoronary streptokinase for myocardial infarctionThe American Journal of Cardiology, 1984
- Prospective randomized trial of intravenous and intracoronary streptokinase in acute myocardial infarction.Circulation, 1983
- Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial InfarctionNew England Journal of Medicine, 1980